20250195491. Novel Pomalidomide Derivative, (AEVIS BIO, .)
NOVEL POMALIDOMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
Abstract: a pomalidomide derivative exhibiting effects better than those of pomalidomide, a preparation method therefor, and use thereof. the pomalidomide derivative has excellent binding force to cereblon, has low cytotoxicity, has a low potential for causing teratogenic side effects, can regulate the expression of tnf-� and proinflammatory cytokines, and has excellent in vivo pharmacokinetic stability even while inhibiting oxidative stress.
Inventor(s): Dong Seok KIM, Inho HWANG, Sun KIM
CPC Classification: A61K31/454 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250195491